Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more patient- centric models for reporting, analyzing and monitoring of safety data.
However, there is no magic pill or solution to the various challenges facing the industry today.
Visit the Sciformix website at www.sciformix.com
Contact Sciformix at ask@sciformix.com
